BANGKOK – Trade between Thailand and the United States is booming, reaching a massive $110 billion in 2025. While the two nations are closer than ever economically, a few significant speed bumps are slowing down the journey toward a final reciprocal trade deal.
A recent report from the Office of the United States Trade Representative (USTR) highlights that while progress is being made, Washington is still waiting for Bangkok to follow through on several key promises. These “non-tariff barriers” affect everything from the car you drive to the medicine in your cabinet.
Why Your Next SUV Might Cost More
One of the biggest sticking points is how cars are tested and sold. Right now, Thailand follows European safety standards (UNECE). This means that even if a Ford truck or a Tesla meets strict U.S. Federal Motor Vehicle Safety Standards (FMVSS), it still has to undergo expensive extra testing before it can be sold in Thailand.
- The Problem: Added costs and delays for American manufacturers.
- The Impact: Fewer choices for Thai consumers, especially for larger pick-up trucks, SUVs, and new electric vehicles, where U.S. tech leads the way.
- The Commitment: Under a joint framework signed in October 2025, Thailand pledged to start recognizing U.S. standards to make imports easier.
Faster Access to Life-Saving Medicine
It isn’t just about cars; it’s about health. Currently, if an American company develops a new life-saving drug or a high-tech medical device, it faces a long approval process in Thailand—even if it has already been cleared by the U.S. Food and Drug Administration (FDA).
The USTR notes that Thailand committed to accepting U.S. FDA certificates as sufficient proof of safety. If this happens, Thai patients could get access to modern treatments much faster. Reducing this “red tape” would mean that products that are already proven safe wouldn’t have to wait years for local paperwork to catch up.
The Sticking Point: Meat and Farming
Agriculture remains the most “thorny” issue in the relationship. For years, the two countries have argued over ractopamine, a feed additive used in the U.S. but restricted in Thailand.
- Beef: While international bodies have set safe limits for ractopamine, Thailand still restricts certain American beef products.
- Pork: U.S. pork is still largely blocked from the Thai market.
- The Consequence: Because of these restrictions, the U.S. previously suspended about one-sixth of Thailand’s Generalised System of Preferences (GSP) benefits. This means some Thai exports to the U.S. actually face higher taxes because the agricultural dispute isn’t settled.
Looking Ahead to 2026
Despite these challenges, the outlook is mostly positive. Thailand is currently working on three separate Free Trade Agreements (FTAs) this year and has formed a special “response team” to handle trade issues with the U.S.
The goal is simple: create a “reciprocal” deal. This means if Thailand makes it easier for U.S. cars and drugs to enter, the U.S. will likely make it easier for Thai goods to reach American shelves.
For the average person, a successful deal could mean more affordable high-tech cars, faster access to the latest healthcare, and a stronger economy driven by $110 billion in annual exchange. The framework is there; now, both sides just need to cross the finish line.
Trending News:
Canada–Thailand Free Trade Talks: Could Work Permits Get Easier in 2026?
US Calls on Thailand to Ease Trade Barriers: A Turning Point for Autos, Drugs, and Farming?
